Seraina Blümli

Seraina Blümli is an Associate Principal Scientist at AstraZeneca, currently focused on profiling antibody binding in high-throughput assays and developing novel biologic assays. They hold a PhD in Cell Biology from the University of Dundee, where they generated mouse ES cell lines using CRISPR/Cas9 technology and explored chromatin changes. Prior to AstraZeneca, Seraina gained diverse experience as a Research Scientist at MedImmune and as a tutor in chemistry and math. Their early career included internships at Roche, contributing to primer design for SNP studies.